Cargando…
Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788255/ https://www.ncbi.nlm.nih.gov/pubmed/31397342 http://dx.doi.org/10.4103/1673-5374.262578 |
_version_ | 1783458453882142720 |
---|---|
author | Bissaro, Maicol Moro, Stefano |
author_facet | Bissaro, Maicol Moro, Stefano |
author_sort | Bissaro, Maicol |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6788255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-67882552019-10-16 Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment Bissaro, Maicol Moro, Stefano Neural Regen Res Perspective Wolters Kluwer - Medknow 2019-08-07 /pmc/articles/PMC6788255/ /pubmed/31397342 http://dx.doi.org/10.4103/1673-5374.262578 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Perspective Bissaro, Maicol Moro, Stefano Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment |
title | Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment |
title_full | Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment |
title_fullStr | Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment |
title_full_unstemmed | Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment |
title_short | Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment |
title_sort | rethinking to riluzole mechanism of action: the molecular link among protein kinase ck1δ activity, tdp-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788255/ https://www.ncbi.nlm.nih.gov/pubmed/31397342 http://dx.doi.org/10.4103/1673-5374.262578 |
work_keys_str_mv | AT bissaromaicol rethinkingtoriluzolemechanismofactionthemolecularlinkamongproteinkinaseck1dactivitytdp43phosphorylationandamyotrophiclateralsclerosispharmacologicaltreatment AT morostefano rethinkingtoriluzolemechanismofactionthemolecularlinkamongproteinkinaseck1dactivitytdp43phosphorylationandamyotrophiclateralsclerosispharmacologicaltreatment |